A compound initially developed as a cholesterol-fighting agent not only halts the progression of prostate cancer, but also can kill cancerous cells, researchers at the University of Missouri have determined.
A compound initially developed as a cholesterol-fighting agent not only halts the progression of prostate cancer, but also can kill cancerous cells, researchers at the University of Missouri have determined.